PYC Therapeutics Ltd

ASX:PYC ISIN:AU000000PYC7

PYC Therapeutics Ltd (ASX:PYC) is a pre-clinical stage biotechnology company pioneering a new generation of RNA therapeutics that utilise PYC's proprietary library of naturally derived cell penetrating peptides to overcome the major challenges of current genetic medicines. 
 
        

View in Other Languages

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12684

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Australian Market Report of December 20, 2010: IMX Resources (ASX:IXR) Sailed First Shipment of Iron-Copper Ore to China

🕔12/20/2010 1:30:00 PM 12471

Australian Market Report of December 20, 2010 includes: IMX Resources Limited (ASX:IXR) has sailed its first shipment of iron-copper ore to China; Phylogica Limited (ASX:PYC) signed collaboration and licensing deal with Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) received strong copper/silver/cobalt results at Walford Creek in Northwest Queensland; South American Ferro Metals Limited (ASX:SFZ) iron ore production in Brazil exceeds 400,000 tonnes.

Read Full Article

Aegis Equities Research Announce Health and Life Science Review, August 2006

🕔8/15/2006 2:42:55 PM 14339

The August 2006 edition of our Health & Life Science Quarterly Blue Book profiles niche life sciences companies, with a focus on company strategies, key projects and significant milestones.

Read Full Article

PHYLOGICA LIMITED ASX: PYC - Market Briefing - Dr Stewart Washer, CEO

🕔5/2/2006 11:30:00 AM 3839

PHYLOGICA LIMITED (ASX: PYC) - Market Briefing - Dr Stewart Washer, CEO; Boardroomradio is pleased to announce that PHYLOGICA LIMITED (ASX: PYC) has published an audio file. The following presentation

Read Full Article
###

85,904 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 6) (Last 30 Days: 88) (Since Published: 11033) 

Company Data

    Fax
  • 08 9423 8899 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2005/03/30 
  • Homepage
  • www.phylogica.com/

More News Results

  • 2024/11/01: First ADOA Patient Dosed in Clinical Trial*
  • 2024/10/31: Presentation of RP11 Single Dose Data at RANZCO*
  • 2024/10/25: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/10/22: Interim Update on Progress in RP11 Repeat Dose Trials*
  • 2024/10/21: Trading Halt*
  • 2024/10/21: US FDA Grants Orphan Drug Designation to PYC Drug Candidate*
  • 2024/10/14: Notice of Annual General Meeting/Proxy Form*
  • 2024/10/09: 2024 Corporate Governance Statement & Appendix 4G*
  • 2024/10/09: Annual Report to shareholders*
  • 2024/09/26: E&P Healthcare Conference Presentation*
*refer to company website